Today BMS announced the acquisition of IFM Therapeutics, an emerging biotech focused on modulating core innate immune pathways to treat cancer and autoimmune disease.
from Forbes Real Time http://www.forbes.com/sites/brucebooth/2017/08/03/innately-innovative-ifm-therapeutics-acquired-by-bms/
via IFTTT
No comments:
Post a Comment